This includes the possibility of Medicare coverage starting in 2026, which will provide further relief for senior patients
Park EH, Burghardt NS, Dvorak D, Hen R, Fenton AA
Available as Saxenda for weight loss and Victoza for diabetes, it requires daily injections rather than weekly ones
Because no human safety trial for IGF-1 LR3 exists, risk assessment must be extrapolated from the pharmacology of native IGF-1 and from the mechanism of IGF1R activation
Document symptom timing, check blood glucose during episodes, and discuss whether dose adjustment, symptomatic treatment, or mental health referral is appropriate